Medical disorders and orthodontics

Journal of Orthodontics

Volumn 36, Issue CLINICAL SECTION, 2009, Pages 1-21

  Patel, Anjli ^a   Burden, Donald J ^b   Sandler, Jonathan ^c  

^a CHARLES CLIFFORD DENTAL HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Guidelines; Medical disorders; Orthodontics

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG THERAPY; GENERAL ASPECTS OF DISEASE; HEALTH STATUS; HUMAN; HYPERSENSITIVITY; KIDNEY DISEASE; LIVER DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; ORTHODONTICS; PATIENT CARE PLANNING; RESPIRATORY TRACT DISEASE;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DISEASE; DRUG THERAPY; HEALTH STATUS; HUMANS; HYPERSENSITIVITY; KIDNEY DISEASES; LIVER DISEASES; MUSCULOSKELETAL DISEASES; NERVOUS SYSTEM DISEASES; ORTHODONTICS, CORRECTIVE; PATIENT CARE PLANNING; RESPIRATORY TRACT DISEASES;

EID: 73549097773     PISSN: 14653125     EISSN: None     Source Type: Journal    
DOI: 10.1179/14653120723346     Document Type: Article

References (139)

1. Sonis ST. Orthodontic management of selected medically compromised patients: cardiac disease, bleeding disorders, and asthma. Semin Orthod 2004; 10: 277-80.
2. Sheller B, Williams B. Orthodontic management of patients with hematological malignancies. Am J Orthod Dentofacial Orthop 1996; 109: 575-80.
3. Prendergast BD. The changing face of infective endocarditis. Heart 2006; 92: 879-85.
4. Moreillon P, Que Y-A. Infective endocarditis. Lancet 2004; 363: 139-49.
5. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25: 267-76.
6. Danchin N, Duval X, Leport C. Prophylaxis of infective endocarditis: French recommendations 2002. Heart 2005; 91:715-18.
7. Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006; 57: 1035-42.
8. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2008; 139(Suppl): 3S-24S.
9. NICE Short Clinical Guidelines Technical Team. Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures. London: National Institute for Health and Clinical Excellence, 2008.
10. Oliver R, Roberts GJ, Hooper L. Penicillins for the prophylaxis in dentistry. Cochrane Database Systematic Reviews 2004; 2: CD003813.
11. Hobson R, Clark JD. Infective Endocarditis associated with orthodontic treatment: a case report. Br J Orthod 1993; 20: 241-44.
12. Dajani AS. Bacterial endocarditis after minor orthodontic procedures. J Pediatr 1991; 119: 339-40.
13. Biancaiello TM, Romero JR. Bacterial endocarditis after adjustment of orthodontic appliances. J Pediatr 1991; 118: 248-49.
14. Ahlstedt S. Penicillin allergy - can the incidence be reduced? Allergy 1984; 39: 151-64.
15. Misra S, Percival RS, Devine DA, Duggal MS. A pilot study to assess bacteraemia associated with tooth brushing using conventional, electric or ultrasonic toothbrushes. Eur Arch Paediatr Dent 2007; 8: 42-45.
16. Lucas VS, Omar J, Vieira A, Roberts GJ. The relationship between odontogenic bacteraemia and orthodontic treatment procedures. Eur J Orthod 2002; 24: 293-301.
17. Burden DJ, Coulter WA, Johnston CD, Mullally B, Stevenson M. The prevalence of bacteraemia on removal of fixed orthodontic appliances. Eur J Orthod 2004; 26: 443-47.
18. Lucas VS, Kyriazidou, Gelbier, Roberts GJ. Bacteraemia following debanding and gold chain adjustment. Eur J Orthod 2007; 29: 161-65.
19. Lockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient with an acquired coagulopathy. Part 1: coagulopathies from systemic disease. Br Dent J 2003; 195: 439-45.
20. Meechan JG, Greenwood M. General medicine and surgery for dental practitioners Part 9: haematology and patients with bleeding problems. Br Dent J 2003; 195: 305-10.
21. Committee on Dangerous Pathogens (ACDP) and the Spongiform Encephalopathy Advisory Committee (SEAC). Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. Department of Health, UK, June 2003.
22. Economics and operational research division. Risk assessment for vCJD in dentistry. Department of Health, June 2003.
23. Farrugia A. variant Creutzfeldt-Jakob disease and hemophilia - further guidance on assessing the risks of plasma-derived products for treating hemophilia. World Federation of Hemophilia task force on Transmissible Spongiform Encephalopathies, 2004.
24. Grossman RC. Orthodontics and dentistry for the hemophilic patient. Am J Orthod 1975; 68: 391-403.
25. Gupta A, Epstein JB, Cabay RJ. Bleeding disorders of importance in dental care and related patient management. J Canadian Dent Assoc 2007; 73: 77-83.
26. Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaët M, Mercier J. Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 247-50.
27. Burden D, Mullally B, Sandler J. Orthodontic treatment of patients with medical disorders. Eur J Orthod 2001; 23: 363-72.
28. Van Venrooy JR, Proffit WR. Orthodontics care for medically compromised patients: possibilities and limitation. J Am Dent Assoc 1985; 111: 262-66.
29. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 331: 1022-23.
30. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77: 171-92.
31. Sergeant G, Sergeant B. Painful crises in sickle-cell disease. Lancet 1996; 347: 1190-91.
32. Piatt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med 2008; 358: 1352-69.
33. Michaelson J, Bhola M. Oral lesions of sickle cell anemia: case report and review of the literature. J Mich Dent Assoc 2004; 86: 32-35.
34. Alves PV, Alves DK, de Souza MM, Torres SR. Orthodontic treatment of patients with sickle-cell anemia. Angle Orthod 2006; 76: 269-73.
35. Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 10: The paediatric patient. Br Dent J 2003; 195: 367-72.
36. Forsberg CM, Krekmanova L, Dahlöff G. The effect of growth hormone therapy on mandibular and cranial base development in children treated with total body irradiation. Eur J Orthod 2002; 24: 285-92.
37. Athanassiadou F, Tragiannidis A, Rousso I, et al. Bone mineral density in survivors of childhood acute lymphoblastic leukemia. Turk J Pediatr 2006; 48: 101-04.
38. Näsman M, Forsberg CM, Dahllöf G. Disturbances in dental development in long-term survivors after pediatric malignant diseases. Eur J Orthod 1997; 19: 151-59.
39. Dahllöf G, Forsberg CM, Ringdén O, et al. Facial growth and morphology in long-term survivors after bone marrow transplantation. Eur J Orthod 1989; 11: 332-40.
40. Dahllöf G, Huggare J. Orthodontic considerations in the pediatric cancer patients: a review. Semin Orthod 2004; 10: 266-76.
41. Scully C, Cawson RA. Medical Problems in Dentistry, 5th Edn. Edinburgh: Elsevier Churchill Livingstone, 2005.
42. Dahllöf G, Jönsson A, Ulmner M, Huggare J. Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation. Am J Orthod Dentofacial Orthop 2001; 120:459-65.
43. Levander E, Malmgren O, Eliasson S. Evaluation of root resorption in relation to two orthodontic treatment regimes. A clinical experimental study. Eur J Orthod 1994; 16: 223-28.
44. Sulaiman F, Huryn JM, Zlotolow IM. Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria and end results. J Oral Maxillofac Surg 2003; 61: 1123-31.
45. http://www.efanet.org/asthma/index.html
46. McNab S, Battistutta D, Tavernea A, Symons AL. External apical root resorption of posterior teeth in asthmatics after orthodontic movement. Am J Orthod Dentofac Orthop 1999; 116: 545-61.
47. de Valk HW, van der Graaf EA. Cystic fibrosis-related diabetes in adults: where can we go from here? Rev Diabet Stud 2001; 4: 6-12.
48. Akata D, Akhan O. Liver manifestations of cystic fibrosis. Eur J Radiol 2007; 61: 11-17.
49. Ratjen F. Recent advances in cystic fibrosis. Paediatr Respir Rev 2008; 9: 144-48.
50. Primosch RE. Tetracycline discoloration, enamel defects, and dental caries in patients with cystic fibrosis. Oral Surg Oral Med Oral Pathol 1980; 50: 301-08.
51. Kinirons MJ. The effect of antibiotic therapy on the oral health of cystic fibrosis children. Int J Paediatr Dent 1992; 2: 139-43.
52. Fukushima C, Matsuse H, Saeki S, et al. Salivary IgA and oral Candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma 2005; 42: 601-04.
53. Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 2: respiratory system. Br Dent J 2003; 194: 593-98.
54. Dursun AB, Woessner KA, Simon RA, Karasoy D, Stevenson DD. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol 2008; 100: 420-25.
55. Hutchinson S, Clark S. Multiple sclerosis presenting to the dental practitioner: a report of two cases. Dent Update 2001; 28: 516-17.
56. Fiske J, Boyle C. Epilepsy and oral care. Dent Update 2002; 29: 180-87.
57. Fiske J, Shafik HH. Down's syndrome and oral care. Dent Update 2001; 28: 148-56.
58. Gorlin RJ, Cohen Jr MM, Hennekam RCM. Syndromes of the Head and Neck, 4th Edn. Oxford: Oxford University Press, 2001.
59. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003; 16: 165-70.
60. Sheller B. Orthodontic management of patients with seizure disorders. Semin Orthod 2004; 10: 247-51.
61. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontal 1996; 23: 165-75.
62. Hassel TM, Burtner AP, McNeal D, Smith RG. Oral problems and genetic aspects of individuals with epilepsy. Periodontol 2000 1994; 6: 68-78.
63. Sanders B, Weddell JA, Dodge NN. Managing patients who have seizure disorders: dental and medical issues. J Am Dent Assoc 1995; 126: 1641-47.
64. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-39.
65. www.mssociety.org.uk
66. Majola MP, McFayden ML, Connolly C, Nair YP, Govender M. Factors influencing phenytoin-induced gingival enlargement. J Clin Periodont 2000; 27: 506-12.
67. Fiske J, Griffiths J, Thompson S. Multiple sclerosis and oral care. Dent Update 2002; 29: 273-83.
68. Torogulu MS, Bayramoglu O, Yarkin F, Tuli A. Possibility of blood and hepatitis B contamination through aerosols generated during debonding procedures. Angle Orthod 2003; 73: 571-78.
69. Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 5: liver disease. Br Dent J 2003; 195: 71-73.
70. McCarthy GM, Mamandras AH, MacDonald JK. Infection control in the orthodontic office in Canada. Am J Orthod Dentofacial Orthop 1997; 112: 275-81.
71. http://www.diabetes.org.uk/Guide-to-diabetes/What-is-diabetes/ What-is-diabetes/
72. Pinhas-Hamiel O, Dolan L, Daniels S, Stanford D, Khowry P, Zeilter P. Increased incidence of non-insulin dependent diabetes mellitus amongst adolescents. J Pediatr 1996; 128: 608-15.
73. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
74. http://www.diabetes.org.uk/Guide-to-diabetes/Complications/ Long-term-complications/
75. Bensch L, Braem M, van Acker K, Willems G. Orthodontic treatment considerations in patients with diabetes mellitus. Am J Orthod Dentofacial Orthop 2003; 123: 74-78.
76. Walker MR, Lovel SF, Melrose CA. Orthodontic treatment of a patient with a renal transplant and drug induced gingival overgrowth: a case report. J Orthod 2007; 34: 220-228.
77. Dental Practitioners Formulary 1998-2000, British National Formulary No. 36. London: The Royal Pharmaceutical Society of Great Britain and the British Medical Association, 1998.
78. Butterworth C, Chappie I. Drug-induced gingival overgrowth: a case with auto-correction of incisor drifting. Dent Update 2001; 28: 411-16.
79. Shirazi M, Khosrowshahi M, Dehpour AR. The effect of chronic renal insufficiency on orthodontic tooth movement in rats. Angle Orthod 2001; 71: 494-98.
80. http://www.emedicine.com/radio/byname/juvenile-rheuma-toid-arthritis.htm
81. Manners PJ, Diepeveen DA. Prevalence of chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics 1996; 98: 84-90.
82. Calabro JJ. Juvenile rheumatoid arthritis. Clin Paediatr Med Surg 1988; 5: 57-75.
83. Twilt M, Mobers SM, Arends LR, ten Cate R, van Suijlekom-Smit L. Temporomandibular involvement in juvenile idiopathic arthritis. J Rheumatol 2004; 31: 1418-22.
84. Pederson TK. Clinical aspects of orthodontic treatment for children with juvenile chronic arthritis. Acta Odontol Scand 1998; 56: 366-68.
85. Sidiropoulou-Chatzigianni S, Papadopoulos MA, Kolokithas G. Dentoskeletal morphology in children with juvenile idiopathic arthritis compared with healthy children. J Orthod 2001; 28: 53-58.
86. Welbury RR, Thomason JM, Fitzgerald JL, Steen IN, Marshall NJ, Foster HE. Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis. Rheumatology 2003; 42: 1445-51.
87. Pederson TK, Grønhøj J, Melsen B, Herlin T. Condylar condition and mandibular growth during early functional treatment of children with juvenile chronic arthritis, Eur J Orthod 1996; 17: 385-94.
88. Callabro JJ. Juvenile rheumatoid arthritis. Clin Pediatr Med Surg 1988; 5:57-75.
89. Stroustrup P, Kristensen KD, Küseler A, et al. Reduced mandibular growth in experimental arthritis in the temporomandibular joint treated with intra-articular corticosteroid. Eur J Orthod 2008; 30: 111-19.
90. Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 8: Musculoskeletal system. Br Dent J 2003; 195: 243-48.
91. Proffit WR. Treatment planning: the search for wisdom. In Proffit WR, White Jr RP (eds.). Surgical Orthodontic Treatment. St Louis: Mosby, 1991, 159.
92. Kjellberg H, Kiliardis S, Thilander B. Dentofacial growth in orthodontically treated and untreated children with juvenile chronic arthritis (JCA). A comparison with Angle Class II division 1 subjects. Eur J Orthod 1995; 17: 357-73.
93. Prestwood KM, Pilbeam CC, Burleson JA, et al. The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 1994; 79: 366-71.
94. Melton LJ. Epidemiology worldwide. Endocrinol Metab Clin North Am 2003; 32: 1-13.
95. Wong PK, Christie JJ, Wark JD. The effects of smoking on bone health. Clin Sci 2007; 113: 233-41.
96. Shapses SA, Riedt CS. Bone, body weight, and weight reduction: what are the concerns? J Nutr 2006; 136: 1453-56.
97. WHO Scientific Group on the Prevention and Management of Osteoporosis (2000: Geneva, Switzerland). Prevention and management of osteoporosis: report of a WHO scientific group, 2003, available at: http://whqlibdoc.who.int/trs/WHO- TRS-921.pdf.
98. Ashcraft MB, Southard KA, Tolley EA. The effect of corticosteroid-induced osteoporosis on orthodontic tooth movement Am J Orthod Dentofacial Orthop 1992; 102: 310-19.
99. Bonaiuti D, Shea B, Iovine R, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2002; (3): CD000333. doi:10.1002/14651858.CD000333. PMID 12137611.
100. Pazanias M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007; 29: 1548-58.
101. Advisory task force on Bisphosphonate-related osteonecrosis of the jaws, Americal Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369-375.
102. Arias OR, Marquez-Orozco MC. Aspirin, acetaminophen, and ibuprofen: their effects on orthodontic tooth movement. Am J Orthod Dentofacial Orthop 2006; 130: 364-70.
103. de Carlos F, Cobo J, Perillan C, et al. Orthodontic tooth movement after different coxib therapies. Eur J Orthod 2007; 29: 596-99.
104. http://www.mca.gov.uk/ourwork/monitorsafequalmed/currentproblems/ volume24may.htm.
105. Gibson N, Ferguson JW. Steroid cover for dental patients on long-term steroid medication: proposed clinical guidelines based upon a critical review of the literature. Br Dent J 2004; 197: 681-85.
106. Thomason JM, Girdler NM, Kendall-Taylor P, Wastell H, Weddel A, Seymour RA. An investigation into the need for supplementary steroids in organ transplant patients undergoing gingival surgery: a double-blind, split-mouth, cross-over study. J Clin Periodontal 1999; 26: 577-82.
107. Kalia S, Melsen B, Verna C. Tissue reaction to orthodontic tooth movement in acute and chronic corticosteroid treatment. Orthod Craniofac Res 2004; 7: 26-34.
108. Igarashi K, Mitani H, Adachi H, Shinoda H. Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movement in rats. Am J Orthod Dentofacial Orthop 1994; 106: 279-89.
109. Advisory task force on Bisphosphonate-related osteonecrosis of the jaws, Americal Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369-75.
110. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg 2005; 63: 1567-75.
111. Barker K, Rogers S. Bisphosphonate-associated osteoradionecrosis of the jaws: a guide for the General Dental Practitioner. Dent Update 2006; 33: 270-75.
112. Graham JW. Bisphosphonates and orthodontics: clinical implications. J Clin Orthod 2006: 40: 425-28.
113. Zahrowski JJ. Bisphosphonate treatment: an orthodontic concern calling for a proactive approach. Am J Orthod Dentofacial Orthop 2007; 131: 311-20.
114. Rinchuse DJ, Rinchuse DJ, Sosovicka MF, Robison JM, Pendleton R. Orthodontic treatment of patients using bisphosphonates: a report of 2 cases. Am J Orthod Orthop 2007; 131: 321-26.
115. Lin JH. Bisphosphonates: a review of the pharmacokinetic properties. Bone 1996; 18: 75-85.
116. Chabria D, Weintraub RG, Kilpatrick NM. Mechanisms and management of gingival overgrowth in paediatric transplant patients: a review. Int J Paediatr Dent 2003; 13: 220-29.
117. Marvogiannis M, Ellis JS, Thomason JM, Seymour RA. The management of drug-induced gingival overgrowth. J Clin Periodontal 2006; 33: 434-39.
118. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000; 27: 144-48.
119. Boyd RL, Baumrind S, Periodontal considerations in the use of bonds or bands on molars in adolescents and adults. Angle Orthod 1992; 62: 117-26.
120. Poley GE Jr, Slater JE. Latex allergy. J Allergy Clin Immunol 2000; 105: 1054-62.
121. Working Party of Resuscitation council (UK). Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. January 2008; 20, available at: http://www.resus.org.uk/pages/reaction.pdf
122. Nielson NH, Menne T. Nickel sensitisation and ear piercing in an unselected Danish population. Contact Dermatitis 1993; 29: 16-21.
123. Hostynek JJ. Sensitization to nickel: etiology, epidemiology, immune reactions, prevention and therapy. Rev Environ Health 2006; 21: 253-80.
124. Bass JK, Fine H, Cisneros GJ. Nickel sensitivity in the orthodontic patient. Am J Orthod Dentofac Orthop 1993; 103: 280-85.
125. Barrett RD, Bishara SE, Quinn YK. Biodegradation of orthodontic appliances. Part 1: biodegradation of nickel and chromium in vitro. Am J Orthod Dentofac Orthop 1993; 103: 8-14.
126. Schiff N, Boinet M, Morgan L, et al. Galvanic corrosion between orthodontic wires and brackets in fluoride mouthwashes. Eur J Orthod 2006; 28: 298-304.
127. Dunlap CL, Vincent SK, Barker BF. Allergic reaction to orthodontic wire: report of a case. J Am Dent Assoc 1989; 118: 449-450.
128. Noble J, Ahing SI, Karaiskos NE, Wiltshire WA. Nickel allergy and orthodontics, a review and report of two cases. Br Dent J 2008; 204: 297-300.
129. Leite LP, Bell RA. Adverse hypersensitivity reactions in orthodontics. Semin Orthod 2004; 10: 240-43.
130. ADA Council on Scientific Affairs. The dental team and latex hypersensitivity. J Am Dent Assoc 1999; 130: 257-64.
131. Isola S, Ricciardi L, Saitta S, et al. Latex allergy and fruit cross-reaction in subjects who are non atopic. Allergy Asthma Proc 2003; 24: 193-97.
132. Hain MA, Longman LP, Field E, Harrison J. Natural rubber latex allergy: implications for the orthodontist. J Orthod 2007; 34: 6-11.
133. Field EA, Longman LP. Guidance for the management of natural rubber latex allergy in dental patients and dental healthworkers. London: Faculty of General Dental Practitioners (UK), The Royal College of Surgeons, 2004.
134. Russell KA, Milne AD, Khanna RA, Lee JM. In vitro assessment of the mechanical properties of latex and non latex orthodontic elastics. Am J Orthod Dentofacial Orthop 2004; 126: 65-70.
135. Ashcroft A, Milosevic A. The eating disorders: 1. Current scientific understanding and dental implications. Dent Update 2007; 34: 544-54.
136. Neeley WW, Kluemper GT, Hays LR. Psychiatry in orthodontics. Part 1: typical adolescent psychiatric disorders and their relevance to orthodontic practice. Am J Orthod Dentofacial Orthop 2006; 129: 176-84.
137. Burke FJT, Bell TJ, Ismail N, Hartley P. Bulimia: implications for the practising dentist. Br Dent J 1996; 180: 421-26.
138. Crossley ML, Shearer AC, Mellor AC, Bridgeman AM. Treatment planning for the problem patient: restorative, ethical, legal and psychological perspectives. Dent Update 2001; 28: 241-46.
139. Ashcroft A, Milosevic A. The eating disorders: 2. Behavioural and dental management. Dent Update 2007; 34: 612-20.